Randomized clinical trial of retinal thermofusion for retinal detachment repair without tamponade using an investigational device, iseelr

The Defense Health Agency (DHA) awarded $1,919,965 to Centre For Eye Research Australia LIMITED (operating as the University of Melbourne Department of Ophthalmology) under the Military Medical Research and Development program (CFDA 12.420) on September 30, 2025. This three-year project grant, with an ultimate completion date of September 29, 2028, supports a randomized clinical trial evaluating retinal thermofusion as an investigational device treatment for retinal detachment repair without tamponade. The research is being conducted in Australia and represents the DHA's investment in advanced ophthalmological innovations with potential applications for both military personnel and civilian patients.

The project deliverables include clinical trial outcomes, efficacy and safety data for the investigational retinal thermofusion device, and evidence-based findings regarding alternative treatment approaches for retinal detachment that may reduce dependence on traditional tamponade methods. As part of the DHA's broader Military Medical Research and Development portfolio, this award supports hypothesis-driven clinical research aimed at transforming healthcare through innovative medical interventions relevant to military readiness and public health.